Together, these data demonstrate that inhibition of vascular endothelial PHD2 signaling significantly attenuates aging-related obesity, exercise intolerance, and glucose intolerance. This evidence concerns the gene EGLN1 and obesity due to melanocortin 4 receptor deficiency.